Cristiano Ronaldo Invests in AI-Driven Personalized Healthcare Venture Bioniq

This investment follows a $15 million Series B funding round in July, bringing Bioniq’s total valuation to $82 million.

Cristiano Ronaldo has invested an undisclosed amount in Bioniq, a custom supplement company specializing in personalized healthcare.

This investment follows a $15 million Series B funding round in July, bringing Bioniq’s total valuation to $82 million.

Bioniq has experienced significant growth, increasing its member base more than five times this year.

Further, the company employs a user quiz and an AI-powered algorithm, utilizing extensive blood biomarker data to create personalized daily supplements for each user. Each formula may contain a unique blend of up to 120 antioxidants, vitamins, minerals, phytonutrients, amino acids, and prebiotic fiber.

Ronaldo, who became a member of Bioniq in 2022, expressed his enthusiasm for the investment. “Backing Bioniq goes beyond just an investment opportunity for me — it’s about aligning with a shared vision for health, performance, and longevity,” he stated.

“I have been using their products myself for almost three years. With their personalized health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer,” The football icon added.

This investment marks another step in Ronaldo's involvement in wellness initiatives; he is also a global ambassador for the health-tracking device brand Whoop.

Vadim Fedotov, co-founder and CEO of Bioniq, said, “We are thrilled that the world’s leading athlete and advocate of a healthy lifestyle has made Bioniq part of his journey since 2022. His personal experience with our products reinforces his belief in what we’re building. Cristiano’s decision to invest highlights his confidence in our team’s vision and his commitment to helping us build the leading company in personalized health.”

Bioniq's products are available in over 70 countries, and the latest investment will support expansion efforts in key markets, particularly in the US, which accounts for over 60% of the business, as well as Europe and the Middle East.

Stay tuned for more such updates on Digital Health News.